Incidence of thrombotic complications in critically ill ICU patients with COVID-19

Klok, F.A., Kruip, M.J.H.A., van der Meer, N.J.M., Arbous, M.S., Gommers, D.A.M.P.J., Kant, K.M., Kaptein, F.H.J., van Paassen, J. +3 more·2020·Thrombosis Research
DOI 10.1016/j.thromres.2020.04.013

Cited by (1,012)

Items 601–700 of 1,012

  1. Inhibition of metalloproteinases in therapy for severe lung injury due to COVID-19
    Boris Solun, Yehuda Shoenfeld · 2020 · Medicine in Drug Discovery
  2. Endpoints for randomized controlled clinical trials for COVID-19 treatments
    Lori Elizabeth Dodd, Dean A. Follmann, Jing Wang, Franz König, Lisa L. Korn, Christian Schoergenhofer, Michael A. Proschan, Sally Hunsberger, Tyler Bonnett, Mat Makowski et al. · 2020 · Clinical Trials
  3. Pros and cons for use of statins in people with coronavirus disease-19 (COVID-19)
    Subir Ray, Mukherjee Jagat J, Kalyan Kumar Gangopadhyay · 2020 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
  4. Clinical characteristics and predictors of mortality in African‐Americans with COVID‐19 from an inner‐city community teaching hospital in New York
    Vijay Bhaskar Reddy Gayam, Muchi Ditah Chobufo, Mohamed A. Merghani, Shristi Lamichhane, Pavani Reddy Garlapati, Mark K. Adler · 2020 · Journal of Medical Virology
  5. In vivo demonstration of microvascular thrombosis in severe COVID-19
    Douglas Alexandre do Espírito Santo, Anna Cristina Bertoldi Lemos, Carlos Henrique Miranda · 2020 · Journal of Thrombosis and Thrombolysis
  6. A Review of Pathophysiology, Clinical Features, and Management Options of COVID-19 Associated Coagulopathy
    Julie Goswami, Taleen A. MacArthur, Meera R. Sridharan, Rajiv K. Pruthi, Robert D. McBane, Thomas Elmer Witzig, Myung S. Park · 2020 · Shock
  7. Hematological changes associated with COVID‐19 infection
    Enass Abdul Kareem Dagher Al‐Saadi, Marwa Ali Abdulnabi · 2021 · Journal of Clinical Laboratory Analysis
  8. Coagulation changes and thromboembolic risk in COVID-19 obstetric patients
    Dan Benhamou, H. Keïta, Anne Sophie Ducloy-Bouthors, Dan Benhamou, Marie‐Pierre Bonnet, Martine Bonnin, Anne Sophie Bouthors, Lionel Bouvet, Adeline Castel, DOMINIQUE CHASSARD et al. · 2020 · Anaesthesia Critical Care & Pain Medicine
  9. Universal Testing for COVID-19 in Essential Orthopaedic Surgery Reveals a High Percentage of Asymptomatic Infections
    Jordan A. Gruskay, Aleksey Dvorzhinskiy, Maxwell A. Konnaris, Drake G. LeBrun, Gregory C. Ghahramani, Ajay Premkumar, Christopher J. DeFrancesco, Christopher L. Mendias, William M. Ricci · 2020 · Journal of Bone and Joint Surgery
  10. COVID-19: Are we dealing with a multisystem vasculopathy in disguise of a viral infection?
    Ritwick Mondal, Durjoy Lahiri, Shramana Deb, Deebya Bandyopadhyay, Gourav Shome, Sukanya Sarkar, Sudeb R. Paria, Tirthankar Guha Thakurta, Pratibha Singla, Subhash Chandra Biswas · 2020 · Journal of Thrombosis and Thrombolysis
  11. Incidence of symptomatic venous thromboembolism following hospitalization for coronavirus disease 2019: Prospective results from a multi-center study
    Farid Rashidi, Stefano Barco, Farin Kamangar, Gustavo A. Heresi, Ashkan Emadi, Cıhangır Kaymaz, Pavel Jansa, Abílio Reis, Arash Rashidi, Ali Taghizadieh et al. · 2020 · Thrombosis Research
  12. Presentations and mechanisms of CNS disorders related to COVID-19
    Marta Bodro, Yaroslau Compta, Raquel Sánchez‐Valle · 2020 · Neurology Neuroimmunology & Neuroinflammation
  13. Why Is COVID-19 More Severe in Patients With Diabetes? The Role of Angiotensin-Converting Enzyme 2, Endothelial Dysfunction and the Immunoinflammatory System
    Jacob Roberts, Antonia L. Pritchard, Andrew T. Treweeke, Adriano Giorgio Rossi, Nicole Brace, Paul Aidan Cahill, Sandra M MacRury, Jun Wei, Ian L. Megson · 2021 · Frontiers in Cardiovascular Medicine
  14. Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies
    Alessandro Allegra, Vanessa Innao, Andrea Gaetano Allegra, Caterina Musolino · 2020 · Annals of Hematology
  15. COVID‐19 and immunological regulations – from basic and translational aspects to clinical implications
    Michael Peter Schön, Carola Berking, Tilo Biedermann, Timo Buhl, Luise Erpenbeck, Kilian Eyerich, Stefanie Eyerich, Kamran Ghoreschi, Matthias Goebeler, Ralf Joachim Ludwig et al. · 2020 · JDDG Journal der Deutschen Dermatologischen Gesellschaft
  16. Micro-RNAs in the regulation of immune response against SARS CoV-2 and other viral infections
    Tareq Abu‐Izneid, Noora Alhajri, Abdallah Mohammad Ibrahim, Md. Noushad Javed, Khairi Mustafa Fahelelbom, Faheem Hyder Pottoo, Mohammad Amjad Kamal · 2020 · Journal of Advanced Research
  17. Cardiovascular implications of COVID-19 versus influenza infection: a review
    Muhammad Shahzeb Khan, Izza Shahid, Stefan D. Anker, Scott David Solomon, Orly Vardeny, Erin D. Michos, Gregg C. Fonarow, Javed Butler · 2020 · BMC Medicine
  18. High Levels of Neutrophil Extracellular Traps Persist in the Lower Respiratory Tract of Critically Ill Patients With Coronavirus Disease 2019
    Werner J. D. Ouwendijk, Matthijs P. Raadsen, Jeroen J. A. van Kampen, Robert M. Verdijk, Jan H. von der Thüsen, Lihui Guo, Rogier A.S. Hoek, Johannes P. C. van den Akker, Henrik Endeman, Thomas Langerak et al. · 2021 · The Journal of Infectious Diseases
  19. Clinical features and outcomes of critically ill patients with coronavirus disease 2019 (COVID-19): A multicenter cohort study
    Khalid A. Al Sulaiman, Ohoud A. Aljuhani, Khalid Eljaaly, Aisha A. Alharbi, Adel M. Alshabasy, Alawi S. Alsaeedi, Mashael Al Mutairi, Hisham A. Badreldin, Shmeylan A. Al Harbi, Hussain Al Haji et al. · 2021 · International Journal of Infectious Diseases
  20. Early mobilization and physical exercise in patients with COVID-19: A narrative literature review
    Verônica Lourenço Wittmer, Flávia Marini Paro, Halina Duarte, Verena Kise Capellini, Marcela Cangussu Barbalho‐Moulim · 2021 · Complementary Therapies in Clinical Practice
  21. Inflammatory Mediators of Platelet Activation: Focus on Atherosclerosis and COVID-19
    Panagiotis Theofilis, Μarios Sagris, Alexios S. Antonopoulos, Evangelos K. Oikonomou, Costas P. Tsioufis, Dimitris Tousoulis · 2021 · International Journal of Molecular Sciences
  22. SARS-CoV-2 deregulates the vascular and immune functions of brain pericytes via Spike protein
    Rayan Khaddaj‐Mallat, Natija Aldib, Maxime Bernard, Anne-Sophie Paquette, Aymeric Ferreira, Sarah Lecordier, Armen Saghatelyan, Louis Flamand, Ayman ElAli · 2021 · Neurobiology of Disease
  23. COVID‐19 with dermatologic manifestations and implications: An unfolding conundrum
    Nawaf Almutairi, Robert Allen Schwartz · 2020 · Dermatologic Therapy
  24. COVID-19 and coagulative axis: review of emerging aspects in a novel disease
    Matilde Boccia, Luigi Aronne, Benito Celia, Grazia Mazzeo, Maria Ceparano, Vito D’Agnano, Roberto Parrella, Tullio Valente, Andrea Bianco, Fabio Perrotta · 2020 · Monaldi Archives for Chest Disease
  25. COVID-19-associated coagulopathy
    Massimo Franchini, Giuseppe Marano, Mario Cruciani, Carlo Mengoli, Ilaria Pati, Francesca Masiello, Eva Veropalumbo, Simonetta Pupella, Stefania Vaglio, Giancarlo Maria Liumbruno · 2020 · Diagnosis
  26. Is the COVID‐19 thrombotic catastrophe complement‐connected?
    Edward M. Conway, Edward L.G. Pryzdial · 2020 · Journal of Thrombosis and Haemostasis
  27. A higher D-dimer threshold for predicting pulmonary embolism in patients with COVID-19: a retrospective study
    Sofía Ventura‐Díaz, Juan V. Quintana-Pérez, Almudena Gil-Boronat, Marina Herrero-Huertas, Luis Gorospe‐Sarasúa, José Montilla, José Acosta Batlle, Javier Blázquez-Sánchez, Agustina Vicente-Bártulos · 2020 · Emergency Radiology
  28. A Clinic Blueprint for Post-Coronavirus Disease 2019 RECOVERY
    Denyse D. Lutchmansingh, Melissa P. Knauert, Danielle E Antin-Ozerkis, Geoffrey Lowell Chupp, Lauren E. Cohn, Charles S. Dela Cruz, Lauren E. Ferrante, Erica L. Herzog, Jonathan L. Koff, Carolyn L. Rochester et al. · 2020 · CHEST Journal
  29. Clinical characteristics and outcomes of critically ill patients with COVID-19 admitted to an intensive care unit in London: A prospective observational cohort study
    Ross J Thomson, Jennifer Hunter, Jonathan Dutton, James W. Schneider, Maryam Khosravi, Alisha Casement, Kulwant Dhadwal, Daniel Martín · 2020 · PLoS ONE
  30. Post-COVID-19 functional status
    Aliae AR Mohamed Hussein, Aliae A. R. Mohamed Hussein, Mahmoud M. Saad, Hossam Eldeen E Zayan, Mustafa Z Abdelsayed, Mohamed M Moustafa, Abdel Rahman Ezzat, Radwa ED Helmy, Howaida K Abd- Elaal, Karim Aly et al. · 2021 · Annals of Thoracic Medicine
  31. Arterial Mesenteric Thrombosis as a Complication of SARS-CoV-2 Infection
    Lia a Beccara, Carlotta Pacioni, Sara Ponton, Simone Francavilla, Antonio Cuzzoli · 2020 · European Journal of Case Reports in Internal Medicine
  32. Adult congenital heart disease and the COVID-19 pandemic
    Robert Radke, Tim Frenzel, Helmut Baumgartner, Gerhard‐Paul Diller · 2020 · Heart
  33. Could Ergothioneine Aid in the Treatment of Coronavirus Patients?
    Irwin Kee-Mun Cheah, Barry B. Halliwell · 2020 · Antioxidants
  34. Multisystem effects of COVID-19: a concise review for practitioners
    Gabrielle A. White-Dzuro, Lauren E. Gibson, L. Zazzeron, Colin G. White-Dzuro, Zachary P. Sullivan, Daren A. Diiorio, Sarah A. Low, Marvin G. Chang, Edward A. Bittner · 2020 · Postgraduate Medicine
  35. Platelet reactivity to thrombin differs between patients with COVID-19 and those with ARDS unrelated to COVID-19
    Younes Zaid, Fadila Guessous, Florian Puhm, Wail Elhamdani, Lamyae Chentoufi, Andrew Conway Morris, Amine Cheikh, Farid Jalali, Éric Boilard, Louis Flamand · 2021 · Blood Advances
  36. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients
    Adam C. Cuker, Eric K. Tseng, Robby Nieuwlaat, Pantep Angchaisuksiri, Clifton Blair, Kathryn E. Dane, Jennifer G. Davila, Maria Teresa DeSancho, David L. Diuguid, Daniel O. Griffin et al. · 2021 · Blood Advances
  37. Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications
    Pulok Kumar Mukherjee, Thomas Efferth, Bhaskar Das, Amit Kar, Suparna Ghosh, Seha Singha, Pradip Debnath, Nanaocha Sharma, Pardeep Kumar Bhardwaj, Pallab Kanti Haldar · 2022 · Phytomedicine
  38. Heparin-induced thrombocytopenia is associated with a high risk of mortality in critical COVID-19 patients receiving heparin-involved treatment
    Xuan Liu, Xiaopeng Zhang, Yongjiu Xiao, Ting Gao, Guangfei Wang, Zhongyi Wang, Zhang Zhang, Yong Hu, Qincai Dong, Songtao Zhao et al. · 2020 · medRxiv
  39. Cold agglutinin autoimmune haemolytic anaemia associated with novel coronavirus (COVID‐19)
    Emily Zagorski, Tushar A. Pawar, Shoja Rahimian, Daniel A. Forman · 2020 · British Journal of Haematology
  40. Urgent Peritoneal Dialysis in Patients With COVID-19 and Acute Kidney Injury: A Single-Center Experience in a Time of Crisis in the United States
    Maryanne Y. Sourial, Mina H. Sourial, Rochelle Dalsan, Jay A. Graham, Michael J. Ross, Wei Chen, Ladan Golestaneh · 2020 · American Journal of Kidney Diseases
  41. Coagulopathy in COVID-19: Focus on vascular thrombotic events
    Wei Shi, Jiagao Lv, Li Lin · 2020 · Journal of Molecular and Cellular Cardiology
  42. Pathogenetic profiling of COVID-19 and SARS-like viruses
    Zulkar Nain, Humayan Kabir Rana, Píetro Lió, Sheikh Mohammed Shariful Islam, Matthew A. Summers, Mohammad Ali Moni · 2020 · Briefings in Bioinformatics
  43. Prophylactic anticoagulants for people hospitalised with COVID-19
    Ronald LG Flumignan, Jéssica Dantas de Sá Tinôco, Patricia Irene Ferreira Pascoal, Libnah Leal Areias, Marcelly Santos Cossi, Maria ICD Fernandes, Isabelle KF Costa, Larissa Gonçalves Souza, Charbel Fadi Matar, Britta Tendal et al. · 2020 · Cochrane Database of Systematic Reviews
  44. Can N-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications?
    Ahmed M. Darwesh, Wesam Bassiouni, Deanna K. Sosnowski, John M. Seubert · 2020 · Pharmacology & Therapeutics
  45. Diagnosis-wide analysis of COVID-19 complications: an exposure-crossover study
    William K. Murk, Monica Gierada, Michael Fralick, Andrew R. Weckstein, Reyna Klesh, Jeremy A. Rassen · 2020 · Canadian Medical Association Journal
  46. Serum troponin, D‐dimer, and CRP level in severe coronavirus (COVID‐19) patients
    Ayad M. Ali, Hassan Muhammad Rostam, Mohammed Hassan Fatah, Chalak M. Noori, Kameran Mohammed Ali, Hassan Mohammad Tawfeeq · 2021 · Immunity Inflammation and Disease
  47. Immunosenescence and inflamm-ageing in COVID-19
    Mohammad Reza Zinatizadeh, Peyman Kheirandish Zarandi, Mohsen Ghiasi, Hamid Kooshki, Mozafar Mohammadi, Jafar Amani, Nima Rezaei · 2022 · Ageing Research Reviews
  48. Preceding infection and risk of stroke: An old concept revived by the COVID-19 pandemic
    Kieron South, Laura J. McCulloch, Barry W. McColl, Mitchell S.V. Elkind, Stuart McRae Allan, Craig J. Smith · 2020 · International Journal of Stroke
  49. Venous thromboembolism in non-critically ill patients with COVID-19 infection
    Antonin Trimaille, Anaïs Curtiaud, Benjamin Marchandot, Kensuke Matsushita, Chisato Sato, Ian Léonard-Lorant, Laurent Sattler, L. Grunebaum, Mickaël Ohana, Jean‐Jacques Von Hunolstein et al. · 2020 · Thrombosis Research
  50. Higher Intensity Thromboprophylaxis Regimens and Pulmonary Embolism in Critically Ill Coronavirus Disease 2019 Patients
    Fabio Silvio Taccone, Pierre Alain Gevenois, Lorenzo Peluso, Zoé Pletschette, Olivier Lheureux, Alexandre Brasseur, Alessandra Garufi, Marta Talamonti, Serge Motte, Leda Nobile et al. · 2020 · Critical Care Medicine
  51. Preliminary Post-Mortem COVID-19 Evidence of Endothelial Injury and Factor VIII Hyperexpression
    Luigi Cipolloni, Francesco Sessa, Giuseppe Bertozzi, Benedetta Baldari, Santina Cantatore, Roberto Testi, Stefano D’Errico, Giulio Di Mizio, Alessio Asmundo, Sergio Castorina et al. · 2020 · Diagnostics
  52. Pituitary apoplexy associated with acute COVID-19 infection and pregnancy
    Julie Lynn Chan, Kimberly D. Gregory, Sarah S. Smithson, Mariam Naqvi, Adam N. Mamelak · 2020 · Pituitary
  53. Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, and the Renin-Angiotensin System
    Matthew A. Sparks, Andrew Michael South, Andrew D. Badley, Carissa Marrie Baker-Smith, DANIEL C. BATLLE, Biykem Bozkurt, Roberto Cattaneo, Steven D. Crowley, Louis J. Dell’Italia, Andria L. Ford et al. · 2020 · Hypertension
  54. Mesenchymal Stem Cell-Derived Extracellular Vesicles Carrying miRNA as a Potential Multi Target Therapy to COVID-19: an In Silico Analysis
    Iago Carvalho Schultz, Ana Paula Santin Bertoni, Márcia Rosângela Wink · 2021 · Stem Cell Reviews and Reports
  55. COVID-19 and Its Implications for Thrombosis and Anticoagulation
    Samuel A. Berkman, Victor F. Tapson · 2021 · Seminars in Respiratory and Critical Care Medicine
  56. Cardiovascular biomarkers in patients with COVID-19
    Christian Eugen Mueller, Evangelos Giannitsis, Allan S. Jaffe, Kurt Huber, Johannes M Mair, Louise Cullen, Ola Hammarsten, Nicholas L. Mills, Martin M. Möckel, Konstantin Alexander Krychtiuk et al. · 2021 · European Heart Journal Acute Cardiovascular Care
  57. Biomarkers of coagulation, endothelial function, and fibrinolysis in critically ill patients with COVID‐19: A single‐center prospective longitudinal study
    Ganeem K. Juneja, Matthew Castelo, Calvin H. Yeh, Samantha E. Cerroni, Bettina E. Hansen, James E. Chessum, Joel Abraham, Erblin Cani, Dhruva J. Dwivedi, Douglas D. Fraser et al. · 2021 · Journal of Thrombosis and Haemostasis
  58. Coronavirus blood-clot mystery intensifies
    Cassandra Willyard · 2020 · Nature
  59. Coronavirus Disease 2019, Prothrombotic Factors, and Venous Thromboembolism
    Sam Schulman · 2020 · Seminars in Thrombosis and Hemostasis
  60. Review of Burden, Clinical Definitions, and Management of COVID-19 Cases
    Laura McArthur, Dhanasekaran Sakthivel, Ricardo Ataíde, Felicia Chan, Jack S. Richards, Charles A. Narh · 2020 · American Journal of Tropical Medicine and Hygiene
  61. Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines
    Pierre Fontana, Alessandro Casini, Helia Robert‐Ebadi, Fréderic Glauser, Marc Righini, Marc Blondon · 2020 · Swiss Medical Weekly
  62. Leveraging the United States Epicenter to Provide Insights on COVID‐19 in Patients With Systemic Lupus Erythematosus
    Ruth Fernandez‐Ruiz, Mala Masson, Mimi Kim, Benjamin Myers, Rebecca H. Haberman, Rochelle Castillo, José U. Scher, Allison Guttmann, Philip M. Carlucci, Kristina Deonaraine et al. · 2020 · Arthritis & Rheumatology
  63. Multimodality Imaging in Evaluation of Cardiovascular Complications in Patients With COVID-19
    Lawrence Rudski, James L. Januzzi, Vera H. Rigolin, Erin Ann Bohula, Ron Blankstein, Amit R. Patel, Chiara Bucciarelli‐Ducci, Esther B. Vorovich, Monica Mukherjee, Sunil V. Rao et al. · 2020 · Journal of the American College of Cardiology
  64. Thrombotic Complications of COVID-19 Infection
    Rebecca A. Castro, William H. Frishman · 2020 · Cardiology in Review
  65. Greater Fibrinolysis Resistance but No Greater Platelet Aggregation in Critically Ill COVID-19 Patients
    Christoph Heinz, Wolfgang Miesbach, Eva Maria Herrmann, Michael Sonntagbauer, Florian Jürgen Raimann, Kai D. Zacharowski, Christian Friedrich Weber, Elisabeth Adam · 2021 · Anesthesiology
  66. SARS-CoV-2 uses major endothelial integrin αvβ3 to cause vascular dysregulation in-vitro during COVID-19
    Danielle Nader, Nicola F. Fletcher, Gerard F. Curley, Steven W. Kerrigan · 2021 · PLoS ONE
  67. Venous Thromboembolism in COVID-19: Towards an Ideal Approach to Thromboprophylaxis, Screening, and Treatment
    Madan Raj Aryal, Rohit Gosain, Anthony Andrew Donato, Ranjan Pathak, Vijaya Raj Bhatt, Anjan Katel, Peter A. Kouides · 2020 · Current Cardiology Reports
  68. Potential Anti-COVID-19 Therapeutics that Block the Early Stage of the Viral Life Cycle: Structures, Mechanisms, and Clinical Trials
    Rami A. Al‐Horani, Srabani Kar, Kholoud F. Aliter · 2020 · International Journal of Molecular Sciences
  69. Complement C5 inhibition in patients with COVID-19 - a promising target?
    Régis Peffault de Latour, Anne Bergeron, Étienne Lengliné, Thibault Dupont, Armance Marchal, Lionel Galicier, Nathalie De Castro, Louise Bondeelle, Michaël Darmon, Clairelyne Dupin et al. · 2020 · Haematologica
  70. Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory
    Michael J Hardy, Thomas Lecompte, Jonathan Douxfils, Sarah Lessire, Jean‐Michel Dogné, Bernard Châtelain, Sophie Testa, Isabelle Gouin‐Thibault, Yves Gruel, Robert Lindsay Medcalf et al. · 2020 · Thrombosis Journal
  71. Poststroke motor and cognitive impairments: clinical features and current approaches to rehabilitation
    Oleg Semenovich Levin, Anna Nicolaevna Bogolepova · 2020 · S S Korsakov Journal of Neurology and Psychiatry
  72. Impact of High-Dose Prophylactic Anticoagulation in Critically Ill Patients With COVID-19 Pneumonia
    Charles Ambroise Tacquard, Alexandre Mansour, Alexandre Godon, Julien Godet, Julien Poissy, Delphine Garrigue, Éric Kipnis, Sophie Hamada, Paul‐Michel Mertès, A. Steib et al. · 2021 · CHEST Journal
  73. COVID-19 Coagulopathy: Current knowledge and guidelines on anticoagulation
    Joshua Kuimeta Salabei, Troy J. Fishman, Zekarias T. Asnake, Arroj Ali, Uma G Iyer · 2021 · Heart & Lung
  74. The emerging association between COVID-19 and acute stroke
    Laura Katherine Stein, Naomi A. Mayman, Mandip S. Dhamoon, Johanna T Fifi · 2021 · Trends in Neurosciences
  75. Anticoagulants for people hospitalised with COVID-19: a rapid review
    Ronald LG Flumignan, Vinicius T Civile, Jéssica Dantas de Sá Tinôco, Patricia IF Pascoal, Libnah L Areias, Charbel F Matar, Britta Tendal, Virgínia Fernandes Moça Trevisani, Álvaro N Atallah, Luis CU Nakano · 2022 · Cochrane Database of Systematic Reviews
  76. Infection of lung megakaryocytes and platelets by SARS-CoV-2 anticipate fatal COVID-19
    Aiwei Zhu, Fernando Real, Claude Capron, Arielle R. Rosenberg, Aymeric Silvin, Garett Dunsmore, Jaja Zhu, Andréa Cottignies-Calamarte, Jean‐Marc Massé, Pierre Moine et al. · 2022 · Cellular and Molecular Life Sciences
  77. Neonatal Coronavirus 2019 (COVID-19) Infection: A Case Report and Review of Literature
    Vikramaditya Dumpa, Ranjith Kamity, Alexandra Vinci, Estela Noyola, Asif Noor · 2020 · Cureus
  78. Characteristics of Acute Pulmonary Embolism in Patients With COVID-19 Associated Pneumonia From the City of Wuhan
    Jianpu Chen, Xiang Wang, Shutong Zhang, Bin Lin, Xiaoqing Wu, Yanfang Wang, Xiaoqi Wang, Ming Yang, Jianqing Sun, Yuanliang Xie · 2020 · Clinical and Applied Thrombosis/Hemostasis
  79. Risk factors for mortality in hospitalized patients with COVID-19 at the start of the pandemic in Belgium: a retrospective cohort study
    Karlijn van Halem, Robin Bruyndonckx, Jeroen C.H. van der Hilst, Janneke Cox, Paulien Driesen, Matthias Opsomer, Eveline Van Steenkiste, Björn Stessel, Jasperina Dubois, Peter Messiaen · 2020 · BMC Infectious Diseases
  80. Coagulation profile of COVID-19 patients admitted to the ICU: An exploratory study
    Thiago Domingos Corrêa, Ricardo Luiz Cordioli, Joao Carlos Guerra, Bruno Caldin da Silva, Roseny dos Reis Rodrigues, Guilherme Martins de Souza, Thais Dias Midega, Niklas Söderberg Campos, Bárbara Vieira Carneiro, Flávia Nunes Dias Campos et al. · 2020 · PLoS ONE
  81. Severe acute kidney injury in critically ill COVID-19 patients
    Gastón Julio Piñeiro, Alícia Molina Andújar, Evelyn Hermida, Miquel Blasco, Luis Fernando Quintana, G. Muñoz-Rojas, Jordi Mercadal, Pedro Castro, Elena Sandoval, Rut Andrea et al. · 2021 · Journal of Nephrology
  82. COVID‐19: Thrombosis, thromboinflammation, and anticoagulation considerations
    Jerrold H. Levy, Toshiaki Iba, Lyra B. Olson, Kristin Corey, Kamrouz Ghadimi, Jean M. Connors · 2021 · International Journal of Laboratory Hematology
  83. The suboptimal fibrinolytic response in COVID‐19 is dictated by high PAI‐1
    Claire S. Whyte, Megan Simpson, Gael B. Morrow, Carol A. Wallace, Alexander J. Mentzer, Julian Charles Knight, Susan Shapiro, Nicola S. Curry, Catherine N. Bagot, Henry G. Watson et al. · 2022 · Journal of Thrombosis and Haemostasis
  84. Risk of mortality in COVID-19 patients: a meta- and network analysis
    Rasoul Kowsar, Amir Mohammad Rahimi, Magdalena Sroka, Alireza Mansouri, Khaled Sadeghi, Elham Bonakdar, Sayed Farshad Kateb, Amir Hossein Mahdavi · 2023 · Scientific Reports
  85. Acute Thrombosis of an Aortic Prosthetic Graft in a Patient with Severe COVID-19–Related Pneumonia
    Elena Giacomelli, Walter Dorigo, Aaron Thomas Fargion, Gianmarco Calugi, Giovanni Cianchi, Carlo Pratesi · 2020 · Annals of Vascular Surgery
  86. Management of Cardiovascular Disease During Coronavirus Disease (COVID-19) Pandemic
    Sarju Ganatra, Sourbha S. Dani, Sachin P. Shah, Aarti H. Asnani, Tomas G. Neilan, Daniel John Lenihan, Bonnie Ky, Ana Barac, Salim S. Hayek, Monika Jacquelina Leja et al. · 2020 · Trends in Cardiovascular Medicine
  87. Cholesterol: A new game player accelerating vasculopathy caused by SARS-CoV-2?
    Xiaoling Cao, Rong H. Yin, Helmut Albrecht, Daping Fan, Wenbin Tan · 2020 · American Journal of Physiology-Endocrinology and Metabolism
  88. COVID-19 and Venous Thromboembolism in Intensive Care or Medical Ward
    Giampiero Avruscio, Giuseppe Camporese, Elena Campello, Enrico Bernardi, Paolo Persona, Christian Passarella, Franco Noventa, Marco Cola, Paolo Navalesi, Anna Maria Cattelan et al. · 2020 · Clinical and Translational Science
  89. Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection
    Andrea T. Obi, Geoffrey D. Barnes, Lena M. Napolitano, Peter K. Henke, Thomas W. Wakefield · 2020 · Journal of Vascular Surgery Venous and Lymphatic Disorders
  90. COVID-19 and stroke: A review
    Xiaoming Qi, Kristin A. Keith, Jason Haitao Huang · 2020 · Brain Hemorrhages
  91. Anti-phospholipid syndrome and COVID-19 thrombosis: connecting the dots
    Moon Ley Tung, Bryce W. Q. Tan, Robin Cherian, Bharatendu Chandra · 2021 · Rheumatology Advances in Practice
  92. Fibrinolysis Shutdown in COVID-19: Clinical Manifestations, Molecular Mechanisms, and Therapeutic Implications
    Jonathan P. Meizoso, Hunter B. Moore, Ernest Eugene Moore · 2021 · Journal of the American College of Surgeons
  93. Antithrombin and Its Role in Host Defense and Inflammation
    Christine Schlömmer, Anna K. Brandtner, Mirjam Bachler · 2021 · International Journal of Molecular Sciences
  94. Pathology of lung‐specific thrombosis and inflammation in COVID‐19
    Хисматуллин Рафаэль Рафикович, Anastasia A. Ponomareva, Chandrasekaran Nagaswami, Rozalina A. Ivaeva, Kathleen T. Montone, John W. Weisel, Литвинов Рустем Игоревич · 2021 · Journal of Thrombosis and Haemostasis
  95. Gegen Qinlian pills alleviate carrageenan-induced thrombosis in mice model by regulating the HMGB1/NF-κB/NLRP3 signaling
    Xiaohan Wei, Baoping Zhang, Feiyan Wei, Mengze Ding, Zhen‐Ye Luo, Xinlong Han, Xiaomei Tan · 2022 · Phytomedicine
  96. Post-Pulmonary Embolism Syndrome and Functional Outcomes after Acute Pulmonary Embolism
    Dieuwke Luijten, Cindy M.M. de Jong, Maarten K. Ninaber, Martijn A. Spruit, Menno Volkert Huisman, Frederikus Albertus Klok · 2022 · Seminars in Thrombosis and Hemostasis
  97. COVID-19 and Cardiac Arrhythmias
    Martin Duckheim, Jürgen Schreieck · 2021 · Hämostaseologie
  98. COVID-19 versus HIT hypercoagulability
    Warkentin, Theodore E., Kaatz, Scott · 2020 · Thrombosis Research
  99. COVID‐19 therapy with mesenchymal stromal cells (MSC) and convalescent plasma must consider exosome involvement: Do the exosomes in convalescent plasma antagonize the weak immune antibodies?
    Philip W. Askenase · 2020 · Journal of Extracellular Vesicles
  100. Impact of oral anticoagulation on clinical outcomes of COVID-19: a nationwide cohort study of hospitalized patients in Germany
    Georg Fröhlich, Elke Jeschke, Uwe Eichler, Hölger Thiele, Laila Alhariri, Markus Reinthaler, Adnan Kastrati, David M. Leistner, Carsten Skurk, Ulf Landmesser et al. · 2021 · Clinical Research in Cardiology